Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Improving outcomes for people with skin tumours including melanoma

Cancer service guideline
Reference number: CSG8
Published: 22 February 2006
Last updated: 25 May 2010

History

Stakeholder list updated

Stakeholder list (PDF 111 KB)

Published:

30 May 2019

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF version) (PDF 1.02 MB)

Published:

19 March 2019
Comments form (MSWord 29 KB)

Published:

19 March 2019

Other information

Skin tumours including melanoma: evidence update (PDF 534 KB)

Published:

01 October 2011
Evidence reviews
Improving outcomes for people with skin tumours including melanoma (update): the management of low-risk basal cell carcinomas in the community - evidence review (2010 partial guidance update evidence review) (PDF 385 KB)

Published:

25 May 2010
Improving outcomes for people with skin tumours including melanoma: the evidence review (2006 evidence review) (PDF 2.07 MB)

Published:

21 February 2006
Analysis of potential economic impact information
Analysis of potential economic impact (PDF 380 KB)

Published:

26 May 2010

Background information

2006/009 NICE issues guidance to improve healthcare services for skin cancers (PDF 45 KB)

Published:

22 February 2006

Skin cancer (update): stakeholder lists and how to register

Skin cancer (update): list of registered stakeholders (PDF 16 KB)

Published:

24 March 2010

Skin cancer (update): guideline development and consultation

Skin cancer (update): guideline development and consultation
Skin cancer (update): GDG membership list (PDF 14 KB)

Published:

19 October 2009
Skin cancer (update): GDG 2 minutes: 21st January 2010 (PDF 18 KB)

Published:

04 August 2010
Skin cancer (update): GDG 1 minutes: 9/10 November 2009 (PDF 16 KB)

Published:

18 May 2010
Skin cancer (update): consultation on the draft guidance information
Skin cancer (update): management of low-risk basal cell carcinomas in the community (PDF 262 KB)

Published:

23 November 2009
Skin cancer (update): evidence review (PDF 585 KB)

Published:

23 November 2009
Skin cancer (update): comments pro forma (MSWord 54 KB)

Published:

23 November 2009
registered stakeholder organisation (PDF 9.8 KB)

Published:

05 July 2012
Skin cancer (update): equality impact assessment form (guideline) (MSWord 74 KB)

Published:

10 November 2010

Skin cancer (update): pre-publication check

Skin cancer (update): pre-publication check information
Skin cancer update: PPC report table with responses (PDF 247 KB)

Published:

24 May 2010
Skin cancer update: guideline (PDF 472 KB)

Published:

01 April 2010
Skin cancer update: evidence review (PDF 577 KB)

Published:

01 April 2010
Skin cancer update: stakeholder comments and responses to draft guideline (PDF 1.02 MB)

Published:

01 April 2010